推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Breast Cancer

2023年12月最新中科院分区表数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

按期刊名首写字母查看 BREAST CANCER-T最新评论：在哪里 (2024-03-17)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


Breast Cancer期刊基本信息Hello，您是该期刊的第36622位访客


基本信息 登录收藏
期刊名字Breast CancerBreast Cancer

BREAST CANCER-TOKYO
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
5.2
50人评分
我要评分

声誉
6.4

影响力
3.9

速度
7.0

期刊ISSN1340-6868
微信扫码收藏此期刊
E-ISSN1880-4233
2022-2023最新影响因子
（数据来源于搜索引擎）		4 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日：3.116
2022-2023自引率2.50%点击查看自引率趋势图
五年影响因子3.8
h-index 47
CiteScore
CiteScoreSJRSNIPCiteScore排名
5.600.8821.077
学科分区排名百分位
大类：Medicine
小类：Radiology, Nuclear Medicine and Imaging		Q280 / 312
大类：Medicine
小类：Pharmacology (medical)		Q278 / 260
大类：Medicine
小类：Oncology		Q2141 / 366

期刊简介
Breast Cancer, the official journal of the Japanese Breast Cancer Society, publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research, seeking to develop a new focus and new perspectives for all who are concerned with breast cancer. The journal welcomes all original articles describing clinical and epidemiological studies and laboratory investigations regarding breast cancer and related diseases. The journal will consider five types of articles: editorials, review articles, original articles, case reports, and rapid communications. Although editorials and review articles will principally be solicited by the editors, they can also be submitted for peer review, as in the case of original articles. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.
期刊官方网站https://www.springer.com/12282
期刊投稿网址https://www.editorialmanager.com/brca
作者指南网址https://www.springer.com/12282/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Breast Cancer的语言要求，还能让Breast Cancer编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Breast Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问No
通讯方式SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, JAPAN, 105-6005
出版商Springer Japan
涉及的研究方向ONCOLOGY-OBSTETRICS & GYNECOLOGY
出版国家或地区JAPAN
出版语言English
出版周期6 issues per year
出版年份1994
年文章数 103点击查看年文章数趋势图
Gold OA文章占比26.57%
研究类文章占比：
文章 ÷（文章 + 综述）		86.41%
WOS期刊SCI分区
（ 2022-2023年最新版）		WOS分区等级：1区

按学科分区JIF分区JIF排名JIF百分位
学科：OBSTETRICS & GYNECOLOGY
类别：SCIE		Q117/85
学科：ONCOLOGY
类别：SCIE		Q296/241
中科院《国际期刊预警
名单（试行）》名单 		2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中科院SCI期刊分区
（ 2023年12月最新升级版） 		点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区3区4区
OBSTETRICS & GYNECOLOGY
妇产科学		1区3区3区
ONCOLOGY
肿瘤学		1区2区4区
否否
中科院SCI期刊分区
（ 2022年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 1区3区2区
OBSTETRICS & GYNECOLOGY
妇产科学		3区2区3区
ONCOLOGY
肿瘤学		2区4区4区
否否
中科院SCI期刊分区
（ 2021年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 2区3区4区
OBSTETRICS & GYNECOLOGY
妇产科学		3区2区3区
ONCOLOGY
肿瘤学		3区1区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1340-6868%5BISSN%5D
平均审稿速度网友分享经验：
较慢,6-12周
平均录用比例网友分享经验：
容易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Breast Cancer顺利发表。
快看看作者怎么说吧：服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Breast Cancer期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Breast Cancer中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Breast Cancer上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of Gynecologic Oncology307.50
    Women and Birth316.40
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE609683
    BIOMATERIALS519586
    BIOMEDICINE & PHARMACOTHERAPY473032
    Journal of Materials Chemistry B464603
    Frontiers in Pharmacology457336
    Frontiers in Immunology429227
    JOURNAL OF ETHNOPHARMACOLOGY411900
    COLLOIDS AND SURFACES B-BIOINTERFACES407880
    Frontiers in Oncology389671
    Acta Biomaterialia380903
  •  

    Breast Cancer Breast Cancer
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node

    Author: Liao, Ning; Li, Cheukfai; Cao, Li; Chen, Yanhua; Ren, Chongyang; Chen, Xiaoqing; Mok, Hsiaopei; Wen, Lingzhu; Li, Kai; Wang, Yulei; Zhang, Yuchen; Li, Yingzi; Lv, Jiaoyi; Cao, Fangrong; Luo, Yuting; Li, Hongrui; Wu, Wendy; Balch, Charles M.; Giuliano, Armando E.
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 1, pp. 77-87. DOI: 10.1007/s12282-022-01400-x        PubMed      DOI
    2.Conservative axillary surgery is emerging in the surgical management of breast cancer

    Author: Noguchi, Masakuni; Inokuchi, Masafumi; Yokoi-Noguchi, Miki; Morioka, Emi; Haba, Yusuke
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 1, pp. 14-22. DOI: 10.1007/s12282-022-01409-2        PubMed      DOI
    3.Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer

    Author: Ma, Jiulong; Wang, Fengjun; Chen, Chen; Ji, Jiahua; Huang, Peng; Wei, Dexian; Zhang, Yang; Ren, Liqun
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 379-392. DOI: 10.1007/s12282-023-01433-w        PubMed      DOI
    4.Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis

    Author: Jiao, Yile; Guo, Xinyi; Lv, Qing
    Journal: BREAST CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12282-023-01459-0        PubMed      DOI
    5.HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC

    Author: Li, Jing-Jing; Yu, Yue; Ge, Jie
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 364-378. DOI: 10.1007/s12282-022-01431-4        PubMed      DOI
    6.Construction and characterization of a cuproptosis- and immune checkpoint-based LncRNAs signature for breast cancer risk stratification

    Author: Li, Yan; Na, Feiyang; Pei, Jianying
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 393-411. DOI: 10.1007/s12282-023-01434-9        PubMed      DOI
    7.Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)

    Author: Imoto, Shigeru; Wang, Kun; Bi, Xi-wen; Liu, Guangyu; Im, Young-Hyuck; Im, Seock-Ah; Sim, Sung Hoon; Ueno, Takayuki; Futamura, Manabu; Toi, Masakazu; Fujiwara, Yasuhiro; Ahn, Sung Gwe; Lee, Jeong Eon; Park, Yeon Hee; Takao, Shintaro; Oba, Mari Saito; Kitagawa, Yuko; Nishiyama, Masahiko
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 412-423. DOI: 10.1007/s12282-023-01436-7        PubMed      DOI
    8.Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer

    Author: Qing, Xin; Yuan, Chunlei; Wang, Ke
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 424-435. DOI: 10.1007/s12282-023-01435-8        PubMed      DOI
    9.Dynamic network biomarker to determine the critical point of breast cancer stage progression

    Author: Jiang, Fa; Yang, Lifeng; Jiao, Xiong
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 453-465. DOI: 10.1007/s12282-023-01438-5        PubMed      DOI
    10.Construction of a prognostic risk assessment model for HER2+breast cancer based on autophagy-related genes

    Author: Wang, Fan; Fang, Linghui; Fu, Bifei; Fan, Chen
    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 478-488. DOI: 10.1007/s12282-023-01440-x        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    COMMUNICATIONS OF THE ACM1899.80
    Qualitative Research in Psychology010.80
    Industrial and Organizational Psychology-Perspectives on Science and Practice05.90
    JOURNAL OF MEDICAL VIROLOGY10523.40
    Travel Medicine and Infectious Disease3717.10
    General Psychiatry018.90
    PSYCHIATRY AND CLINICAL NEUROSCIENCES669.70
    CLINICAL NUCLEAR MEDICINE532.60
    MedComm05.20
    Tourism Geographies022.00


以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

    同领域作者分享投稿经验：共17条 （包含回复）

 我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

    增值电信业务经营许可证：沪B2-20211595

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451